Rheumatology Network Newsletter

To view this email as a web page, click here.

New Drug Approvals and more Drug News from Rheumatology Network

In rheumatology, there have been five new drug approvals in recent months for patients with axial spondyloarthritis, plaque psoriasis and osteoporosis. Learn more about the new treatments and other drug news in this slideshow.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.